Frontline treatment approaches in TP53-aberrant mantle cell lymphoma. Shah NN, Castillo-Tokumori F, Whiting J, Boulware D, et al. Leuk Lymphoma 2022 Oct 27:1-4. doi: 10.1080/10428194.2022.2131407.

Read + Share

Amedeo Smart

Independent Medical Education

Shah NN, Castillo-Tokumori F, Whiting J, Boulware D, et al. Frontline treatment approaches in TP53-aberrant mantle cell lymphoma. Leuk Lymphoma 2022 Oct 27:1-4. doi: 10.1080/10428194.2022.2131407.
PMID: 36301721